NOVOMIX 30 100 U/ML SUS INJ CT 5 CAR VD TRANS X 3 ML (PENFILL)
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1176600170014 -
GGREM
526602002155316 -
Código de barras
7897705201060
O que a fonte publica
- Detentor do registro
- NOVO NORDISK FARMACÊUTICA DO BRASIL LTDA
- Princípios ativos
- INSULINA ASPARTE
- Embalagem
- 100 U/ML SUS INJ CT 5 CAR VD TRANS X 3 ML (PENFILL)
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- A10C3 - Insulinas humanas e análogos, ação intermediária e longa, comb. com ação rápida
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "NOVOMIX 30 100 U/ML SUS INJ CT 5 CAR VD TRANS X 3 ML (PENFILL)",
"holder": "NOVO NORDISK FARMACÊUTICA DO BRASIL LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7897705201060"
],
"confaz87": true,
"currency": "BRL",
"marketed": null,
"ggremCode": "526602002155316",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "82.277.955/0001-55",
"priceRegime": "Regulado",
"productName": "NOVOMIX 30",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "100 U/ML SUS INJ CT 5 CAR VD TRANS X 3 ML (PENFILL)",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "246.75",
"icms-12": "280.40",
"icms-17": "297.29",
"icms-18": "300.91",
"icms-19": "304.63",
"icms-20": "308.44",
"icms-21": "312.34",
"icms-22": "316.35",
"icms-23": "320.45",
"icms-17.5": "299.09",
"icms-19.5": "306.52",
"icms-20.5": "310.38",
"icms-22.5": "318.39",
"icms-12-alc": "277.03",
"icms-17-alc": "293.72",
"icms-18-alc": "297.30",
"icms-19-alc": "300.97",
"icms-20-alc": "304.74",
"icms-21-alc": "308.59",
"icms-22-alc": "312.55",
"icms-23-alc": "316.61",
"withoutTaxes": "243.79",
"icms-17.5-alc": "295.50",
"icms-19.5-alc": "302.84",
"icms-20.5-alc": "306.65",
"icms-22.5-alc": "314.57"
},
"pisCofinsList": "Positiva",
"substanceText": "INSULINA ASPARTE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "340.12",
"icms-12": "386.50",
"icms-17": "409.78",
"icms-18": "414.77",
"icms-19": "419.90",
"icms-20": "425.15",
"icms-21": "430.53",
"icms-22": "436.06",
"icms-23": "441.71",
"icms-17.5": "412.26",
"icms-19.5": "422.51",
"icms-20.5": "427.83",
"icms-22.5": "438.87",
"icms-12-alc": "382.98",
"icms-17-alc": "406.05",
"icms-18-alc": "411.00",
"icms-19-alc": "416.07",
"icms-20-alc": "421.29",
"icms-21-alc": "426.61",
"icms-22-alc": "432.08",
"icms-23-alc": "437.69",
"withoutTaxes": "337.02",
"icms-17.5-alc": "408.51",
"icms-19.5-alc": "418.66",
"icms-20.5-alc": "423.93",
"icms-22.5-alc": "434.87"
},
"invalidBarcodes": [],
"activeSubstances": [
"INSULINA ASPARTE"
],
"therapeuticClass": "A10C3 - Insulinas humanas e análogos, ação intermediária e longa, comb. com ação rápida",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1176600170014",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A10C3",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:526602002155316"